Ivan Collado Caño

Title: Innovations by Ivan Collado Caño

Introduction

Ivan Collado Caño is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological and psychiatric disorders. With a total of two patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

Ivan's latest patents include innovative methods of treatment using a prodrug of an excitatory amino acid. This invention focuses on synthetic excitatory amino acid prodrugs and the processes for their preparation. It also encompasses methods of using these compounds and pharmaceutical compositions for treating neurological and psychiatric disorders. Another significant patent involves melanocortin receptor agonists, which are useful in treating obesity, diabetes, and sexual dysfunction in both males and females.

Career Highlights

Ivan Collado Caño is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Ivan has collaborated with notable colleagues such as Ryan Thomas Backer and Karin Briner. These collaborations have further enriched his research and innovation efforts.

Conclusion

Ivan Collado Caño's contributions to the field of pharmaceuticals through his patents demonstrate his dedication to improving health outcomes. His innovative approaches to treatment highlight the importance of research and development in addressing complex medical challenges.